Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy

• Victoria M. Valvo,
• Victoria M. Valvo,
• Emanuele Vitale,
• Emanuele Vitale,
• Marco Tigano,
• Rachel Evans,
• Rachel Evans,
• Meredith A. Morgan,
• Qiang Zhang

Affiliations

Victoria M. Valvo

Department of Radiation Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States

Victoria M. Valvo

Cancer Biology Program, University of Michigan, Ann Arbor, MI, United States

Emanuele Vitale

Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy

Emanuele Vitale

MitoCare Center, Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA, United States

Marco Tigano

MitoCare Center, Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA, United States

Rachel Evans

Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, London, United Kingdom

Rachel Evans

Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Meredith A. Morgan

Department of Radiation Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States

Qiang Zhang

Department of Radiation Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States